Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Go back to Citi Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 231.46 -4.76 (2.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $236.22 | 52 Week High | $109.10 | |||
| Open | $235.83 | 52 Week Low | $31.38 | |||
| Day High | $236.80 | P/E | N/A | |||
| Day Low | $228.59 | EPS | $-1.45 | |||
| Volume | 971,588 | |||||
